Drugs / ScTIL210
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04357509 | May 2020 → Dec 2021 | melanoma | Peking University Cancer Hospital & Institute | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ScTIL210 | “This is an open-lable, single-arm, single-dose escalation and multiple-dose expansion clinical study of cell therapy to observe and evaluate the tolerance, pharmacokinetic...” NCT04357509 ↗ |
| Route | Intravenous | “one-time intravenous infusion” NCT04357509 ↗ |